SCHEMBL5578378

SCHEMBL5578378

CC(=O)NCCc1nc2ccccc2c(=O)n1-c1ccc(OCC(F)(F)F)cc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 11/20 0.58
FADS1 O60427 1/20 0.56
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
KCNH2 Q12809 1/20 0.49
HRH3 Q9Y5N1 1/20 0.49
BLM P54132 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 1/20 0.48
MAPK1 P28482 1/20 0.48
ALDH1A1 P00352 1/20 0.48
RAB9A P51151 1/20 0.47
ATM Q13315 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5578380 0.83 PDE10A (0.53) PDE10AMEN1KMT2ACYP1A2CYP3A4
SCHEMBL5578698 0.82 MEN1 (0.52) PDE10AMEN1KMT2ACYP1A2CYP3A4
SCHEMBL15154005 0.79 PDE10A (0.77) PDE10AMEN1KMT2ACYP1A2CYP3A4
SCHEMBL27592014 0.79 PDE10A (0.57) PDE10AMEN1KMT2ACYP1A2CYP3A4
SCHEMBL15164727 0.76 PDE10A (0.69) PDE10AMEN1KMT2ACYP1A2CYP3A4
SCHEMBL12659747 0.76 HRH3 (0.54) PDE10AMEN1KMT2ACYP1A2CYP3A4
SCHEMBL18076614 0.76 PDE10A (0.60) PDE10AMEN1KMT2ACYP1A2CYP3A4
SCHEMBL7147056 0.75 PDE10A (0.60) PDE10AMEN1KMT2ACYP1A2CYP3A4
SCHEMBL410424 0.74 PDE10A (1.00) PDE10AMEN1KMT2ACYP1A2CYP3A4
SCHEMBL5578377 0.74 KCNH2 (0.49) KCNH2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1771447-A1 FUSED PYRIMIDINE DERIVATIVES AND COMPOSITIONS THEREOF AS CXCR3 RECEPTOR MODULATORS, USEFUL IN PREVENTION AND TREATMENT OF INFLAMMATORY AND IMMUNOREGULATORY DISORDERS AND DISEASES Amgen SF LLC (US) 2007-04-11 EP disclosed
WO-2006004915-A1 FUSED PYRIMIDINE DERIVATIVES AND COMPOSITIONS THEREOF AS CXCR3 RECEPTOR MODULATORS, USEFUL IN PREVENTION AND TREATMENT OF INFLAMMATORY AND IMMUNOREGULATORY DISORDERS AND DISEASES AMGEN SF, LLC (US) 2006-01-12 WO disclosed